Proton Therapy

Producing LEU-based Mo-99 to reduce the use of HEU

Producing LEU-based Mo-99 to reduce the use of HEU Belgium’s Institute for Radioelements (IRE) announced that the company produced its first commercial Molybdenum-99 Low Enriched Uranium (LEU) batch for the US market. This conversion to LEU represents a key milestone for IRE in the global efforts to end the civil use of High Enriched Uranium…